SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Clinical trials for SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) explained in plain language.

Never miss a new study

Get alerted when new SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) trials appear

Sign up with your email to follow new studies for SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for rare blood cancer: targeted drug trial opens

Disease control Recruiting now

This study tests a new drug called CGT9486 (bezuclastinib) in people with advanced systemic mastocytosis, a rare and serious blood disorder. The drug aims to control the disease by targeting a specific genetic mutation. About 140 adults with aggressive forms of the condition will…

Matched conditions: SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Phase: PHASE2 • Sponsor: Cogent Biosciences, Inc. • Aim: Disease control

Last updated May 17, 2026 05:17 UTC

SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN)

Get alerted when new SM WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM (SM-AHN) trials appear

New hope for rare blood cancer: targeted drug trial opens